Cart
sales@molnova.com
Iberverin
CAS No. 505-79-3
Iberverin( —— )
Catalog No. M21152 CAS No. 505-79-3
Iberverin is a naturan product. It induces phase II enzyme activity and decreases expression of androgen receptors in prostate cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 39 | In Stock |
|
| 1G | 56 | In Stock |
|
Biological Information
-
Product NameIberverin
-
NoteResearch use only, not for human use.
-
Brief DescriptionIberverin is a naturan product. It induces phase II enzyme activity and decreases expression of androgen receptors in prostate cancer cells.
-
DescriptionIberverin is a naturan product. It induces phase II enzyme activity and decreases expression of androgen receptors in prostate cancer cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number505-79-3
-
Formula Weight147.26
-
Molecular FormulaC5H9NS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCSCCCN=C=S
-
Chemical Name(3-isothiocyanatopropyl)(methyl)sulfane
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ernst I M A Palani K Esatbeyoglu T et al. Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin iberin and cheirolin[J]. Pharmacological Research 2013 70(1):155-162.
molnova catalog
related products
-
HAEGTFTSDVSSYLE
HAEGTFTSDVSSYLE is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence.
-
PAC1R antagonist 1
PAC1R antagonist 1 is an orally active PAC1 receptor antagonist that inhibits abnormal pain induced by pituitary adenylate cyclase-activating polypeptide (PACAP) and nerve damage, and may be used in the study of neoplasms and immune-related disorders.
-
FUBP1-IN-1
FUBP1 - in-1, with an IC50 value of 11.0 M, is an effective FUSE binding protein 1 (FUBP1) inhibitor that can interfere with the binding of FUBP1 to its SINGLE-strand target DNA FUSE sequence.
